BridgeMD
New treatment option for Internalizing Problems
Official title Promoting Resilience in Youth Through Mindfulness mEditation
ClinicalTrials.gov ID: NCT05916651
What this study is testing
- What it's testing
- The aim of this randomized controlled trial (RCT) is to assess whether mindfulness training reduces early stage internalizing problems such as anxiety, worrying, and low mood in help-seeking youth. Participants will be randomly assigned to one of two groups: 1) mindfulness + care-as-usual (CAU) or 2) CAU-only.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 25
You may be able to join if
- Youth between 16 and 25 years of age
- Provide written informed consent
- Adequate mastery of Dutch language
You likely can't join if
- Lifetime diagnosis of severe major depression, bipolar disorder, schizophrenia spectrum disorder, personality disorder, and post-traumatic stress...
- History of major medical illness or neurological illness
- Participation in a mindfulness programme in the past year
- Current participation in another intervention study
- Moderate to severe substance use disorders (i.e., we will allow for mild substance use)
- Current active suicidality, current psychotic symptoms above clinical cut-off for psychosis, or current trauma-related complaints above clinical...
See the full eligibility criteria
- Youth between 16 and 25 years of age
- Provide written informed consent
- Adequate mastery of Dutch language
- Lifetime diagnosis of severe major depression, bipolar disorder, schizophrenia spectrum disorder, personality disorder, and post-traumatic stress disorder
- History of major medical illness or neurological illness
- Participation in a mindfulness programme in the past year
- Current participation in another intervention study
- Moderate to severe substance use disorders (i.e., we will allow for mild substance use)
- Current active suicidality, current psychotic symptoms above clinical cut-off for psychosis, or current trauma-related complaints above clinical cut-off for PTSD.
- Diagnosed or suspected (mild) intellectual disability (estimated IQ \< 75)
The study team makes the final eligibility decision.
Where it's taking place
- Nijmegen, Gelderland, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 25 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nijmegen, Gelderland, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.